1,2,4-triazole has been researched along with Extravascular Hemolysis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Anjum, MN; Irfan, A; Kotwica-Mojzych, K; Mansha, A; Mojzych, M; Rasul, A; Shahzadi, I; Tüzün, B; Zahoor, AF | 1 |
Aswathanarayanappa, C; Bheemappa, E; Bodke, YD; Krishnegowda, PS; Ningegowda, R; Venkata, SP | 1 |
2 other study(ies) available for 1,2,4-triazole and Extravascular Hemolysis
Article | Year |
---|---|
Repositioning of acefylline as anti-cancer drug: Synthesis, anticancer and computational studies of azomethines derived from acefylline tethered 4-amino-3-mercapto-1,2,4-triazole.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Repositioning; Drug Screening Assays, Antitumor; Hemolysis; Humans; Liver Neoplasms; Molecular Structure; Structure-Activity Relationship; Triazoles | 2022 |
Synthesis and evaluation of antioxidant properties of novel 1,2,4-triazole-based schiff base heterocycles.
Topics: Antioxidants; Biphenyl Compounds; DNA Damage; Dose-Response Relationship, Drug; Erythrocyte Membrane; Free Radical Scavengers; Hemolysis; Humans; Lipid Peroxidation; Molecular Structure; Oxidative Stress; Phenethylamines; Picrates; Schiff Bases; Triazoles | 2013 |